CLIQX | JVMSX | CLIQX / JVMSX | |
Total Expense Ratio | 0.82 | 1.25 | 66% |
Annual Report Gross Expense Ratio | 1.08 | 1.26 | 86% |
Fund Existence | 6 years | 13 years | - |
Gain YTD | 4.929 | 9.064 | 54% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 125M | 22.9B | 1% |
Annual Yield % from dividends | 2.80 | 0.42 | 670% |
Returns for 1 year | 15.55 | 0.75 | 2,062% |
Returns for 3 years | 24.99 | 20.42 | 122% |
Returns for 5 years | 69.73 | 55.91 | 125% |
Returns for 10 years | N/A | 46.42 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LTTI | 19.31 | 0.08 | +0.41% |
FT Vest 20+ Year Treasury & Target Income ETF | |||
XBI | 87.61 | 0.12 | +0.14% |
SPDR® S&P Biotech ETF | |||
IBIH | 26.13 | 0.02 | +0.10% |
iShares iBonds Oct 2031 Term Tips ETF | |||
RLY | 29.83 | -0.02 | -0.07% |
SPDR® SSgA Multi-Asset Real Return ETF | |||
SOCL | 54.49 | -0.33 | -0.59% |
Global X Social Media ETF |